ADCT
ADC Therapeutics·NYSE
--
--(--)
--
--(--)
3.89 / 10
Netural
Analyst sentiment shows one strong‑buy rating (100%) but zero historical win rate. Sentiment score is 3.89/10, neutral. Fund‑flow rating is good (7.78), with positive inflows across block, medium, large and extra‑large investors, though small‑size flow is negative. Mixed signals prevail.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-23
InstitutionHC Wainwright & Co.
Times predicted3
Historical Win Rate0.0%
What is the analyst consensus for ADCT?
- ADCT holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 3.89/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
